Expression profiles of miRNA subsets distinguish human colorectal carcinoma and normal colonic mucosa

Clinical and Translational Gastroenterology

Volumn 7, Issue 3, 2016, Pages

  Pellatt, Daniel F ^a   Stevens, John R ^b   Wolff, Roger K ^a   Mullany, Lila E ^a   Herrick, Jennifer S ^a   Samowitz, Wade ^a   Slattery, Martha L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HSA MIR 145-5P; HSA MIR 17-5P; HSA MIR 20A-5P; HSA MIR 21-5P; HSA MIR 3651; HSA MIR 378A-3P; HSA MIR 378I; HSA MIR 4506; HSA MIR 4539; HSA MIR 663B; HSA MIR 92A-3P; HSA MIR 93A-5P; MICRORNA; UNCLASSIFIED DRUG;

ADULT; AGED; COLON CARCINOMA; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOM FOREST; RECTUM CARCINOMA; REVIEW;

EID: 84981287697     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2016.11     Document Type: Review

References (49)

1. Arora S, Rana R, Chhabra A et al. miRNA-transcription factor interactions: a combinatorial regulation of gene expression. Mol Genet Genomics 2013;288:77-87.
2. Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005; 15: 563-568.
3. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-5856.
4. Dong Y, Wu WK, Wu CW et al. MicroRNA dysregulation in colorectal cancer: a clinical perspective. Br J Cancer 2011;104:893-898.
5. Luo X, Burwinkel B, Tao S et al. MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev 2011;20:1272-1286.
6. Polytarchou C, Hommes DW, Palumbo T et al. MicroRNA214 is associated with progression of ulcerative colitis, and inhibition reduces development of colitis and colitis-associated cancer in mice. Gastroenterology 2015;149:981-92.e11.
7. Hamfjord J, Stangeland AM, Hughes T et al. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using highthroughput sequencing. PLoS One 2012;7:e34150.
8. Piepoli A, Tavano F, Copetti M et al. Mirna expression profiles identify drivers in colorectal and pancreatic cancers. PLoS One 2012;7:e33663.
9. Reid JF, Sokolova V, Zoni E et al. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res 2012;10:504-515.
10. Slattery ML, Herrick JS, Pellatt DF et al. MicroRNA profiles in colorectal carcinomas, adenomas, and normal colonic mucosa: variations in miRNA expression and disease progression. Carcinogenesis 2016.
11. Svetnik V, Liaw A, Tong C et al. Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci 2003;43:1947-1958.
12. Breiman L. Random forests. Machine Learn 2001; 45: 5-32.
13. Archer KJ, Kimes RV. Empirical characterization of random forest variable importance measures. Comput Stat Data Anal 2008; 52: 2249-2260.
14. Díaz-Uriarte R, Alvarez de Andrés S. Gene selection and classification of microarray data using random forest. BMC Bioinform 2006;7:1-13.
15. Cutler A, Stevens JR. Random forests for microarrays. Methods Enzymol 2006; 411: 422-432.
16. Slattery ML, Potter J, Caan B et al. Energy balance and colon cancer-beyond physical activity. Cancer Res 1997;57:75-80.
17. Slattery ML, Caan BJ, Benson J et al. Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer 2003;46:166-171.
18. Slattery ML, Edwards SL, Palmer L et al. Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of bias. Mutat Res 2000;432: 7-14.
19. Griffiths-Jones S. miRBase: the microRNA sequence database. Methods Mol Biol 2006; 342: 129-138.
20. Core Team R. R: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2015. Available at: http://www.R-project.org/; last accessed on 20 January 2016.
21. Liaw A, Wiener M. Classification and regression by random forest. R News 2002; 2: 18-22.
22. Breiman L, Friedman J, Stone CJ et al. Classification and Regression Trees. Boca Raton, FL: CRC Press, 1984.
23. Vlachos IS, Paraskevopoulou MD, Karagkouni D et al. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res 2015;43:D153-D159.
24. Huang, da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37: 1-13.
25. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocols 2008; 4: 44-57.
26. Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-29.
27. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 2000; 28: 27-30.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001; 25: 402-408.
29. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protocols 2008; 3: 1101-1108.
30. Asangani IA, Rasheed SA, Nikolova DA et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008;27:2128-2136.
31. Baffa R, Fassan M, Volinia S et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009;219:214-221.
32. Schetter AJ, Leung SY, Sohn JJ et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008;299:425-436.
33. Valeri N, Gasparini P, Braconi C et al. MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci USA 2010;107: 21098-21103.
34. Xia X, Yang B, Zhai X et al. Prognostic role of microRNA-21 in colorectal cancer: a metaanalysis. PLoS One 2013;8:e80426.
35. Du M, Shi D, Yuan L et al. Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep 2015;5:10437.
36. Ragusa M, Statello L, Maugeri M et al. Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors. J Mol Med (Berl) 2012;90:1421-1438.
37. Kara M, Yumrutas O, Ozcan O et al. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene 2015;567:81-86.
38. Fang L, Li H, Wang L et al. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression. Oncotarget 2014;5:2974-2987.
39. Okumura T, Shimada Y, Omura T et al. MicroRNA profiles to predict postoperative prognosis in patients with small cell carcinoma of the esophagus. Anticancer Res 2015;35:719-727.
40. Motoyama K, Inoue H, Takatsuno Y et al. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009;34:1069-1075.
41. Nishida N, Nagahara M, Sato T et al. Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Clin Cancer Res 2012;18: 3054-3070.
42. Schee K, Lorenz S, Worren MM et al. Deep sequencing the microRNA transcriptome in colorectal cancer. PLoS One 2013;8:e66165.
43. Bandres E, Cubedo E, Agirre X et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006;5:29.
44. Izzotti A, Calin GA, Steele VE et al. Chemoprevention of cigarette smoke-induced alterations of microRNA expression in rat lungs. Cancer Prev Res (Phila) 2010;3:62-72.
45. Kheirelseid EA, Miller N, Chang KH et al. mRNA/miRNA correlations in colorectal cancer: novel mechanisms in cancer initiation and progression. Int J Colorectal Dis 2013;28: 1031-1034.
46. Nakano H, Miyazawa T, Kinoshita K et al. Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells. Int J Cancer 2009;127:1072-1080.
47. Wu H, Neilson JR, Kumar P et al. miRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2007;2:e1020.
48. Mestdagh P, Hartmann N, Baeriswyl L et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods 2014;11:809-815.
49. Sanz-Pamplona R, Berenguer A, Cordero D et al. Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer. Mol Cancer 2014;13:46.